Impact of bacterial biofilm on the treatment of prosthetic joint infections

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue SUPPL1, 2014, Pages

  Jacqueline, Cédric ^a   Caillon, Jocelyne ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Adhesion; Antibiotic resistance; Biofilms; Joint infections; Osteomyelitis

Indexed keywords

ANTIINFECTIVE AGENT;

BACTERIAL INFECTIONS; BACTERIAL PHENOMENA AND FUNCTIONS; BIOFILM; DRUG COMBINATION; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; OSTEOARTHRITIS; PROCEDURES; PROSTHESIS-RELATED INFECTIONS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BACTERIAL PHYSIOLOGICAL PHENOMENA; BIOFILMS; DRUG THERAPY, COMBINATION; HUMANS; OSTEOARTHRITIS; PROSTHESIS-RELATED INFECTIONS;

EID: 84906826872     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku254     Document Type: Article

References (32)

1. Trampuz A, Osmon DR, Hanssen AD et al. Molecular and antibiofilm approaches to prosthetic joint infection. Clin Orthop Relat Res 2003; 414: 69-88.
2. Richards JJ, Melander C. Controlling bacterial biofilms. Chembiochem 2009; 10: 2287-94.
3. Aparna MS, Yadav S. Biofilms: microbes and disease. Braz J Infect Dis 2008; 12: 526-30.
4. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-22.
5. Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol 2009; 11: 1034-43.
6. Parsek MR, Singh PK. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 2003; 57: 677-701.
7. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002; 8: 881-90.
8. Saginur R, Stdenis M, Ferris W et al. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother 2006; 50: 55-61.
9. Donlan RM. Role of biofilms in antimicrobial resistance. ASAIO J 2000; 46: S47-52.
10. Mataraci E, Dosler S. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrob Agents Chemother 2012; 56: 6366-71.
11. LaPlante KL, Mermel LA. In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strains. Antimicrob Agents Chemother 2009; 53: 3166-9.
12. Dunne WM Jr. Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev 2002; 15: 155-66.
13. Chavant P, Gaillard-Martinie B, Talon R et al. A new device for rapid evaluation of biofilm formation potential by bacteria. J Microbiol Methods 2007; 68: 605-61.
14. Crémet L, Corvec S, Batard E et al. Comparison of three methods to study biofilm formation by clinical strains of Escherichia coli. Diagn Microbiol Infect Dis 2013; 75: 252-5.
15. Stewart PS, Davison WM, Steenbergen JN. Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 2009; 53: 3505-7.
16. DunneWMJr, Mason EO Jr, Kaplan SL. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 1993; 37: 2522-6.
17. Darouiche RO, Dhir A, Miller AJ et al. Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis 1994; 170: 720-3.
18. Zheng Z, Stewart PS. Penetration of rifampin through Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2002; 46: 900-3.
19. Brière M, Caillon J, Jacqueline C et al. Efficacy of daptomycin against Staphylococcus epidermidis in an in vitro-infected fibrin clot model: comparison with vancomycin. In: Abstracts of the Fifteenth Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, MA, 2010. Abstract E-1553. American Society for Microbiology, Washington, DC, USA.
20. Trampuz A, ZimmerliW. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly 2005; 135: 243-51.
21. Parra-Ruiz J, Vidaillac C, RoseWEet al. Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm. Antimicrob Agents Chemother 2010; 54: 4329-34.
22. Gander S, Kinnaird A, Finch R. Telavancin: in vitro activity against staphylococci in a biofilm model. J Antimicrob Chemother 2005; 56: 337-43.
23. Fujimura S, Sato T, Mikami T et al. Combined efficacy of clarithromycin plus cefazolin or vancomycin against Staphylococcus aureus biofilms formed on titanium medical devices. Int J Antimicrob Agents 2008; 32: 481-4.
24. Parra-Ruiz J, Bravo-Molina A, Peña-Monje A et al. Activity of linezolid and high-dose daptomycin, alone or in combination, in an in vitro model of Staphylococcus aureus biofilm. J Antimicrob Chemother 2012; 67: 2682-5.
25. Gomes F, Teixeira P, Ceri H et al. Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms. Indian J Med Res 2012; 135: 542-7.
26. Euba G, Rouse MS, Del Pozo JL et al. Linezolid treatment of Staphylococcus aureus experimental foreign body osteomyelitis. In: Abstracts of the Forty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 2009. Abstract B-1322. American Society for Microbiology, Washington, DC, USA.
27. Vergidis P, Rouse MS, Euba G et al. Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis. Antimicrob Agents Chemother 2011; 55: 1182-6.
28. Saleh-Mghir A, Muller-Serieys C, Dinh A et al. Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2011; 55: 4589-93.
29. Rodríguez-Martínez JM, Ballesta S, García I et al. Activity and penetration of linezolid and vancomycin against Staphylococcus epidermidis biofilms. Enferm Infecc Microbiol Clin 2007; 25: 425-8.
30. Leite B, Gomes F, Teixeira P et al. In vitro activity of daptomycin, linezolid and rifampicin on Staphylococcus epidermidis biofilms. Curr Microbiol 2011; 63: 313-7.
31. Roveta S, Schito AM, Marchese A et al. Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. Int J Antimicrob Agents 2007; 30: 415-21.
32. Jacqueline C, Amador G, Desessard C et al. Assessment of linezolid, vancomycin, and rifampicin as monotherapy in comparison with combination of linezolid/rifampicin and vancomycin/rifampicin in the treatment of experimental methicillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis. In: Abstracts of the Twenty-first European Congress of Clinical Microbiology and Infectious Diseases 2011, Milan, Italy. Abstract P-1504. European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland.